BENLYSTA

Google image searchProduct monograph

Active ingredient

belimumab, 200 MG/1 ML

DIN: 02470489

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: AUTOINJECTOR. SINGLE DOSE.

Schedule: Prescription / Schedule D

Company: GLAXOSMITHKLINE INC

Date: 14-MAY-2018

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AG — Monoclonal antibodies (ATC, ATC/DDD)
• L04AG04 — BELIMUMAB (ATC/DDD)

Reference brand drug: Benlysta

External Links for Benlysta

Search on Google

• Benlysta side effects
• Benlysta dosage
• belimumab side effects
• belimumab dosage

Glaxosmithkline Inc

Go to GlaxoSmithKline website to see drug product details. Sometimes you can find benlysta photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.